Levocetirizine Dihydrochloride Tablet
Product Images NDC 51655-148

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 51655-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 148 52)

Packaging label for Levocetirizine Dihydrochloride Tablets USP 5 mg, oral tablet dosage form, containing 30 tablets per container. Label indicates prescription status with storage instructions and manufacturer information for Northwind Pharmaceuticals, Inc., repackaged by Northwind Health Company, LLC.*

FDA Label Image

Camber1 (Camber1)

FDA Label Image

Levocitirizinestructure (Levocitirizinestructure)

Chemical structure of Levocetirizine Dihydrochloride, showing its molecular components including aromatic rings, nitrogen atoms, and associated hydrochloride groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.